Sanai, N., Mehta, S., Tien, A., Tovmasyan, A., Harmon, J., Kennedy, W. R., Aziez, A., Chalmers, A. J., Khasraw, M., Lim-Fat, M. J., Minniti, G., Sepúlveda, J. M., Touat, M., Umemura, Y. (2025). A global phase 3, open-label, randomized 2-arm study comparing the clinical efficacy and safety of niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps2096